Haoxi Health Technology has experienced a significant increase in its revenue for FY24, with a projected amount of $48.52 million compared to $28.23 million in the previous year.

This growth can be attributed to the company's strategic focus on online advertising solutions, specifically through short video formats and news feed ads. The utilization of Bidding Compass, a proprietary data analysis software, has played a crucial role in optimizing ad placements, contributing to both revenue and profit growth.

The estimated gross profit for FY24 is approximately $2.75 million, representing a 33.4% increase from the previous year. Net income is projected to reach around $1.29 million, reflecting a 33.2% rise.

The total assets of the company have also increased to approximately $15.51 million as of June 30, 2024, showcasing the company's operational scale and effective capital utilization following its initial public offering.

CEO Mr. Zhen Fan emphasized the strength of the business model and the team's ability to adapt in the dynamic online advertising landscape. He expressed optimism about maintaining growth momentum through expanded partnerships and enhanced service offerings, while also highlighting the company's commitment to the healthcare sector.